<DOC>
	<DOCNO>NCT01631578</DOCNO>
	<brief_summary>A prospective randomized control trial ( RCT ) determine effect inject autologous somatic mitochondrion concentrate , together spermatozoon ICSI , oocytes old poor prognosis vitro fertilization ( IVF ) patient .</brief_summary>
	<brief_title>Improving Reproductive Outcome Poor Quality Ova Injection Autologous Somatic Mitochondria</brief_title>
	<detailed_description>Maternal age first delivery constantly rise developed country . Oocyte quality decrease advance age , thus rate age-related infertility continuously increase . Presently oocyte donation prompt solution widespread problem . Deterioration mitochondrial function suggest one explanation age-related deterioration oocyte quality . The supplementation age oocyte autologous mitochondrion divide somatic cell possible solution energetic enrichment , without introduce foreign mtDNA . We establish non-hazardous clinical grade system prepare functional autologous mitochondrion concentrate granulosa cell aspirate oocyte pick . The mitochondrial preparation examine find non-toxic . The activity respiratory chain constant unaffected age ovarian response . Moreover , mtDNA mitochondrial preparation find intact sample examine , include old low responding patient .</detailed_description>
	<criteria>Adequate sperm source uterine cavity . And one following : Age &gt; 40 3 unsuccessful IVF cycle &gt; 75 % embryo previous cycle &gt; 2050 % fragment &lt; 50 % fertilization rate previous cycle Inadequate sperm source . Inadequate uterine cavity .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>mitochondrial injection</keyword>
</DOC>